ADMA Biologics, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

DEBT (Details Narrative)

DEBT (Details Narrative) - USD ($)		1 Months Ended		3 Months Ended			6 Months Ended
DEBT (Details Narrative) - USD ($)	Feb. 11, 2019	May 03, 2019	May 02, 2019	Jun. 30, 2020	Mar. 31, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Perceptive Tranche I Note and Perceptive Tranche II fees paid		$ 5,300,000					$ 30,000,000.0
Interest rate		141.00%
Description of prepaid principal amount							(i) 5.0% of the prepaid principal amount, if prepaid on or prior to the first anniversary of the Perceptive Closing Date, (ii) 4.0% of the prepaid principal amount, if prepaid after the first anniversary of the Perceptive Closing Date and on or prior to the second anniversary of the Perceptive Closing Date, or (iii) 3.0% of the prepaid principal amount, if prepaid after the second anniversary of the Perceptive Closing Date and on or prior to the third anniversary of the Perceptive Closing Date.
Warrant, amount				$ 6,255	$ 7,177	$ 75,048
Warrant exercise price							$ 2.96
Loss on the extinguishment of debt				$ 0		$ 0	$ 0	$ 9,962,495
Perceptive Tranche III Warrant [Member]
Warrant			250,000
Warrant, amount			$ 900,000
Warrant exercise price			$ 4.64
Perceptive Tranche III Loan (Member)
Principal amount of term loan		$ 12,500,000
Perceptive Tranche II Loan (Member)
Principal amount of term loan		27,500,000
Perceptive Tranche I Loan (Member)
Principal amount of term loan							$ 45,000,000.0
BPC (Member)
Interest rate							60.00%
Expiration date							June 6, 2022
Net Cash proceeds							$ 15,000,000.0
Marathon Healthcare Finance Fund, L.P. (Member)
Deferred facility fee		2,800,000
Loss on the extinguishment of debt								(9,962,495)
Prepayment Penalty		6,500,000						6,500,000
Unamortized debt discount								$ 3,500,000
Fees and expenses		1,500,000
Additional facility fee		100,000
Debt service reserve		4,000,000.0
Accrued interest		$ 700,000
Perceptive Credit Agreement [Member]
Principal amount of term loan	$ 85,000,000.0
Additionlal description							In addition, the Company must (i) at all times prior to the Maturity Date maintain a minimum cash balance of $3.0 million; and (ii) as of the last day of each fiscal quarter commencing with the fiscal quarter ended June 30, 2019, report revenues for the trailing 12-month period that exceed the amounts set forth in the Perceptive Credit Agreement, which range from $7.0 million for the fiscal quarter ended June 30, 2019 to $55.0 million for the fiscal quarter ending December 31, 2021.
Interest rate description							Perceptive Credit Agreement bear interest at a rate per annum equal to 7.5% plus the greater of (i) one-month LIBOR and (ii) 3.5%; provided, however, that upon, and during the continuance of, an Event of Default, the interest rate will automatically increase by an additional 400 basis points. Accrued interest is payable to Perceptive on the last day of each month during the term of the Perceptive Credit Facility.The rate of interest in effect as of the Perceptive Closing Date and at June 30, 2020 was 11.0%.
Warrant							1,360,000
Warrant, amount							$ 2,700,000
Expiration date							February 11, 2029
Warrant exercise price							$ 3.28